Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Skin Cancer01:30

Skin Cancer

4.3K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.3K
Management of Insomnia01:19

Management of Insomnia

292
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
292
Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

2.0K
The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Right aortic arch and double arch assessed by prenatal echocardiography: a population-based study.

European heart journal·2026
Same author

Industrial, residential, and treated effluents contribute to synthetic musk pollution in Australian waterways.

Environmental pollution (Barking, Essex : 1987)·2026
Same author

Mental Health Care for Refugees, Immigrants, and Migrants in the United States.

Psychiatric services (Washington, D.C.)·2026
Same author

Spatial omics for profiling the dynamic tumor microenvironment.

Clinical & translational immunology·2026
Same author

Prevalence of pediatric cannabidiol prescribing in the United States.

World journal of pediatrics : WJP·2026
Same author

Definition of Severity and Relapse for Vitiligo: An International Consensus Statement.

JAMA dermatology·2026

Related Experiment Video

Updated: Aug 3, 2025

Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid
04:12

Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid

Published on: January 19, 2024

977

Optimizing Melasma Management With Topical Tranexamic Acid: An Expert Consensus.

Seemal Desai, Lee Chan, Evangeline Handog

    Journal of Drugs in Dermatology : JDD
    |April 7, 2023
    PubMed
    Summary

    Topical tranexamic acid (TXA) offers a new option for managing melasma, a complex skin condition. This review explores TXA

    More Related Videos

    Author Spotlight: Advancing Facial Rejuvenation Therapy with Post-Laser Salicylic Acid Application
    03:47

    Author Spotlight: Advancing Facial Rejuvenation Therapy with Post-Laser Salicylic Acid Application

    Published on: September 27, 2024

    955
    Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
    06:09

    Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

    Published on: June 7, 2019

    8.8K

    Related Experiment Videos

    Last Updated: Aug 3, 2025

    Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid
    04:12

    Author Spotlight: Non-Surgical Treatment of Melasma– Microneedling with Tranexamic Acid

    Published on: January 19, 2024

    977
    Author Spotlight: Advancing Facial Rejuvenation Therapy with Post-Laser Salicylic Acid Application
    03:47

    Author Spotlight: Advancing Facial Rejuvenation Therapy with Post-Laser Salicylic Acid Application

    Published on: September 27, 2024

    955
    Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
    06:09

    Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

    Published on: June 7, 2019

    8.8K

    Area of Science:

    • Dermatology and Cutaneous Science
    • Pharmacology and Therapeutics

    Background:

    • Melasma is a complex, chronic skin condition with high recurrence rates, posing management challenges.
    • Topical treatments are common, but patient awareness of melasma's chronic nature and need for long-term management is often lacking.
    • Hydroquinone is a standard treatment but has side effects; topical tranexamic acid (TXA) is an alternative for specific patient profiles.

    Approach:

    • This review summarizes current evidence on topical TXA for melasma treatment in specific patient cases.
    • It aims to address knowledge gaps regarding available melasma treatment options.
    • The focus is on topical TXA, used alone or in combination with other ingredients, including a 2% TXA formulation with patented delivery technology.

    Key Points:

    • Topical tranexamic acid (TXA) is emerging as a viable treatment for melasma, particularly for patients refractory to or experiencing side effects from other therapies.
    • TXA can be used as a monotherapy or in combination with other active ingredients.
    • Evidence supports TXA's role in managing challenging melasma cases, offering an alternative to traditional treatments like hydroquinone.

    Conclusions:

    • Topical TXA presents a valuable therapeutic option for optimizing melasma management, especially in cases requiring long-term control.
    • Further research and clinical consensus support the use of topical TXA for specific melasma patient profiles.
    • This review highlights the potential of topical TXA to fill existing gaps in melasma treatment strategies.